LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA)
This study is ongoing, but not recruiting participants.
Sponsor:
Baylor College of Medicine
Collaborators:
The Methodist Hospital System
Texas Children's Hospital
Center for Cell and Gene Therapy, Baylor College of Medicine
Information provided by (Responsible Party):
Stephen Gottschalk, Baylor College of Medicine
ClinicalTrials.gov Identifier:
NCT00516087
First received: August 10, 2007
Last updated: October 5, 2012
Last verified: October 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | August 2022 |
| Estimated Primary Completion Date: | August 2022 (Final data collection date for primary outcome measure) |